A Study of Belimumab in the Prevention of Kidney Transplant Rejection
Clinical trial NCT01536379 · COMPLETED
Trial details
- NCT number
- NCT01536379
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2016-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.